Long-term inhibition of mutant LRRK2 hyper-kinase activity reduced mouse brain α-synuclein oligomers without adverse effects
- Standort
-
Deutsche Nationalbibliothek Frankfurt am Main
- ISSN
-
2373-8057
- Umfang
-
Online-Ressource
- Sprache
-
Englisch
- Anmerkungen
-
online resource.
- Erschienen in
-
Long-term inhibition of mutant LRRK2 hyper-kinase activity reduced mouse brain α-synuclein oligomers without adverse effects ; volume:8 ; number:1 ; day:10 ; month:9 ; year:2022 ; pages:1-22 ; date:12.2022
npj Parkinson's Disease ; 8, Heft 1 (10.9.2022), 1-22, 12.2022
- Urheber
-
Ho, Philip Wing-Lok
Chang, Eunice Eun-Seo
Leung, Chi-Ting
Liu, Huifang
Malki, Yasine
Pang, Shirley Yin-Yu
Choi, Zoe Yuen-Kiu
Liang, Yingmin
Lai, Weng Seng
Ruan, Yuefei
Leung, Kenneth Mei-Yee
Yung, Susan
Mak, Judith Choi-Wo
Kung, Michelle Hiu-Wai
Ramsden, David B.
Ho, Shu-Leong
- Beteiligte Personen und Organisationen
-
SpringerLink (Online service)
- DOI
-
10.1038/s41531-022-00386-9
- URN
-
urn:nbn:de:101:1-2022112821082640318657
- Rechteinformation
-
Open Access; Der Zugriff auf das Objekt ist unbeschränkt möglich.
- Letzte Aktualisierung
-
15.08.2025, 07:21 MESZ
Datenpartner
Dieses Objekt wird bereitgestellt von:
Deutsche Nationalbibliothek. Bei Fragen zum Objekt wenden Sie sich bitte an den Datenpartner.
Deutsche Nationalbibliothek. Bei Fragen zum Objekt wenden Sie sich bitte an den Datenpartner.
Beteiligte
- Ho, Philip Wing-Lok
- Chang, Eunice Eun-Seo
- Leung, Chi-Ting
- Liu, Huifang
- Malki, Yasine
- Pang, Shirley Yin-Yu
- Choi, Zoe Yuen-Kiu
- Liang, Yingmin
- Lai, Weng Seng
- Ruan, Yuefei
- Leung, Kenneth Mei-Yee
- Yung, Susan
- Mak, Judith Choi-Wo
- Kung, Michelle Hiu-Wai
- Ramsden, David B.
- Ho, Shu-Leong
- SpringerLink (Online service)
Ähnliche Objekte (12)
α-Synuclein oligomers form by secondary nucleation
Stabilization of α-synuclein oligomers using formaldehyde
LRRK2 kinase regulates α-synuclein propagation via RAB35 phosphorylation
Optical Structural Analysis of Individual α‐Synuclein Oligomers
Optical Structural Analysis of Individual α‐Synuclein Oligomers
Structural characteristics and membrane interactions of tandem α-synuclein oligomers
LRRK2 activity does not dramatically alter α-synuclein pathology in primary neurons
Leucine-rich repeat kinase 2 (LRRK2) regulates α-synuclein clearance in microglia
Pathological α-synuclein recruits LRRK2 expressing pro-inflammatory monocytes to the brain
Dermal α-synuclein oligomers and aggregates in Parkinson’s disease
Tau oligomers mediate α-synuclein toxicity and can be targeted by immunotherapy
Early stages of aggregation of engineered α-synuclein monomers and oligomers in solution
α-Synuclein oligomers form by secondary nucleation
Stabilization of α-synuclein oligomers using formaldehyde
LRRK2 kinase regulates α-synuclein propagation via RAB35 phosphorylation
Optical Structural Analysis of Individual α‐Synuclein Oligomers
Optical Structural Analysis of Individual α‐Synuclein Oligomers
Structural characteristics and membrane interactions of tandem α-synuclein oligomers
LRRK2 activity does not dramatically alter α-synuclein pathology in primary neurons
Leucine-rich repeat kinase 2 (LRRK2) regulates α-synuclein clearance in microglia
Pathological α-synuclein recruits LRRK2 expressing pro-inflammatory monocytes to the brain
Dermal α-synuclein oligomers and aggregates in Parkinson’s disease
Tau oligomers mediate α-synuclein toxicity and can be targeted by immunotherapy
Early stages of aggregation of engineered α-synuclein monomers and oligomers in solution
α-Synuclein oligomers form by secondary nucleation
Stabilization of α-synuclein oligomers using formaldehyde
LRRK2 kinase regulates α-synuclein propagation via RAB35 phosphorylation
Optical Structural Analysis of Individual α‐Synuclein Oligomers
Optical Structural Analysis of Individual α‐Synuclein Oligomers
Structural characteristics and membrane interactions of tandem α-synuclein oligomers
LRRK2 activity does not dramatically alter α-synuclein pathology in primary neurons
Leucine-rich repeat kinase 2 (LRRK2) regulates α-synuclein clearance in microglia
Pathological α-synuclein recruits LRRK2 expressing pro-inflammatory monocytes to the brain
Dermal α-synuclein oligomers and aggregates in Parkinson’s disease
Tau oligomers mediate α-synuclein toxicity and can be targeted by immunotherapy